Interleukin 10 protects activated human T lymphocytes against growth factor withdrawal-induced cell death but only anti-fas antibody can prevent activation-induced cell death

Cytokine

Volumn 8, Issue 12, 1996, Pages 877-881

  Pawelec, Graham ^a   Hambrecht, Andreas ^b   Rehbein, Arnika ^b   Adibzadeh, Medi ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B7 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030499476     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0117     Document Type: Article

References (26)

1. 1. Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1-26.
2. 2. Chen WF, Zlotnik A (1991) IL-10 - a novel cytotoxic T-cell differentiation factor. J Immunol 147:528-534.
3. 3. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A (1990) IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145:4167-4173.
4. 4. Taga K, Cherney B, Tosato G (1993) IL-10 inhibits apoptotic cell death in human T-cells starved of IL-2. Int Immunol 5:1599-1608.
5. 5. Schlaak JF, Hermann E, Gallati H, Zum Buschenfelde KHM, Fleischer B (1994) Differential effects of IL-10 on proliferation and cytokine production of human gamma/delta and alpha/beta T cells. Scand J Immunol 39:209-215.
6. 6. Malefyt RD, Yssel H, De Vries JE (1993) Direct effects of IL-10 on subsets of human CD4 + T-cell clones and resting T-cells - specific inhibition of IL-2 production and proliferation. J Immunol 150:4754-4765.
7. 7. Moore KW, O'Garra A, Malefyt RD, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165-190.
8. 8. Cohen SBA (1995) IL-10 and IL-3 synergize to cause proliferation of human T cells. Immunology 85:351-356.
9. 9. Pawelec G, Pohla H, Schlotz E, Rebbein A, Schandt K, Hambrecht A, Friccius H (1995) Interleukin 10 is a human T cell growth factor in vitro. Cytokine 7:355-363.
10. 10. Fine JS, Macosko HD, Grace MJ, Narula SK (1994) Interleukin-10 enhances gamma delta T cell development in the murine fetal thymus. Cell Immunol 155:111-122.
11. 11. Renauld JC, Vink A, Louahed J, Van Snick J (1995) Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 85:1300-1305.
12. 12. Radrizzani M, Accornero P, Amidei A, et al. (1995) IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol 161:14-21.
13. 13. Eischen CM, Dick CJ, Leibson PJ (1994) Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153:1947-1954.
14. 14. Migita K, Eguchi K, Kawabe Y, Mizokami A, Tsukada T, Nagataki S (1994) Prevention of anti-CD3 monoclonal antibody-induced thymic apoptosis by protein tyrosine kinase inhibitors. J Immunol 153:3457-3465.
15. 15. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438-441.
16. 16. Brunner T, Mogil RJ, Laface D, et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation induced apoptosis in T-cell hybridomas. Nature 373:441-444.
17. 17. Ju ST, Panka DJ, Cui HL, et al. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448.
18. 18. Anel A, Buferne M, Boyer C, Schmitt-Verhulst AM, Golstein P (1994) T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 24:2469-2476.
19. 19. Alderson MR, Tough TW, Davis-Smith T, et al. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71-77.
20. 20. Zheng LX, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348-351.
21. 21. Pawelec G. Cloning and propagation of human T lymphocytes. In Gallagher G, Rees RC, Reynolds CW, eds, Tumour Immunobiology. A Practical Approach. Oxford: IRL Press, 1993:131-41.
22. 22. Pawelec G, Schwuléra U, Blaurock M, et al. (1987) Relative cloning efficiencies and long-term propagation capacity for T cell clones of highly purified natural interleukin 2 compared to recombinant interleukin 2 in man. Immunobiology 174:67-75.
23. 23. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1894:5294-5299.
24. 24. Feinberg AP, Vogelstein B (1983) A technique for radio-labeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
25. 25. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81:1991-1995.
26. 26. Nagata S (1994) Fas and fas ligand: A death factor and its receptor. Adv Immunol 57:129-144.